Aisling Capital vs Canaan Partners
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| Aisling Capital | Canaan Partners | |
|---|---|---|
| Type | Venture capital | Venture capital |
| HQ | New York | Stamford |
| Founded | 2000 | 1994 |
| Check size | — | $500K – $20M |
| Stages | Seed, Series A, Series B, Series C | Pre-Seed, Seed, Series A |
| Sectors | Biotech, Digital Health, Healthtech, Medical Devices | Biotech, Cloud Computing, Consumer, Deep Tech, Digital Health, E-commerce, Enterprise Software, Fintech, Gaming, Healthtech, Medical Devices |
| AUM | $716.4M | $7B |
| Tracked investments | 119 | 380 |
| Exits (acquired/public) | 1 | 4 |
| Led rounds on record | — | 1 |
| Dated deals, last 24 mo | 2 | 15 |
Shared portfolio · 7
Chimerix NASDAQ: CMRX www.chimerix.comDermiraProtagonist TherapeuticsSemnur PharmaceuticalsBiPar SciencesDurata TherapeuticsEsperion Therapeutics
Frequently asked questions
- Do Aisling Capital and Canaan Partners invest together?
- Yes — Aisling Capital and Canaan Partners appear together in 7 tracked portfolio companies, including Chimerix NASDAQ: CMRX www.chimerix.com, Dermira, Protagonist Therapeutics, Semnur Pharmaceuticals, BiPar Sciences.